{"nct_id":"NCT02144051","title":"Phase I Open Label Dose Escalation Study to Investigate the Safety & Pharmacokinetics of AZD5312 in Patients With Androgen Receptor Tumors","status":"COMPLETED","status_verified_date":"2016-07","start_date":"2014-05","start_date_type":null,"primary_completion_date":"2016-03","primary_completion_date_type":"ACTUAL","completion_date":"2016-03","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["AZN"]}